Meb Pharma Consultancy (Opc) Private Limited - Company Profile

It is a business outsourcing enterprise based in Nagpur, Maharashtra, India, established in 2019.
2019 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Meb Pharma Consultancy (Opc) Private Limited

Meb Pharma Consultancy (Opc) Private Limited, Engaging in business & it consulting within the business outsourcing sector, it holds CIN: U24290MH2019OPC330254. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Eknath Pandurang Bhad (Nominee), Mangesh Eknath Bhad (Director). Past directors included Eknath Pandurang Bhad. Its latest balance sheet filed on 31 March 2025. It is based at Nirmal Nagari Building No F.No.7-A Umred Road Nagpur, Nagpur, Maharashtra, 440009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2019OPC330254

  • Registration Number

    330254

  • Incorporation Date

    06 September 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 0.37%
  • Profit Growth **** -20.55%
  • Ebitda **** -17.42%
  • Net Worth 12.45%
  • Total Assets -4.60%
Company report

Meb Pharma Consultancy (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Meb Pharma Consultancy (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Meb Pharma Consultancy (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Eknath Pandurang Bhad Nominee 06 Sep 2019 Current
Mangesh Eknath Bhad Director 06 Sep 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Meb Pharma Consultancy (Opc).

Meb Pharma Consultancy (Opc) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.37% increase. The company also saw a substantial fall in profitability, with a 20.55% decrease in profit. The company's net worth Soared by an impressive increase of 12.45%.

Meb Pharma Consultancy (Opc) revenue growth over time
Meb Pharma Consultancy (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.37%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -4.60%
*******
*******
*******
*******
Profit or Loss
*******
 -20.55%
*******
*******
*******
*******
Net Worth
*******
 12.45%
*******
*******
*******
*******
EBITDA
*******
 -17.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Meb Pharma Consultancy (Opc)?

Unlock access to Meb Pharma Consultancy (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Meb Pharma Consultancy (Opc)?

Unlock and access historical data on people associated with Meb Pharma Consultancy (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Meb Pharma Consultancy (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meb Pharma Consultancy (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Meb Pharma Consultancy (Opc)
Recent Activity within the Organization
  • Balance Sheet

    Progress on Meb Pharma Consultancy (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Eknath Pandurang Bhad was appointed as a Nominee was appointed as a Nominee on 06 Sep 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Director Appointment

    Mangesh Eknath Bhad was appointed as a Director was appointed as a Director on 06 Sep 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Meb Pharma Consultancy (Opc) Private Limited was registered on 06 Sep 2019 with Roc Mumbai & aged 6 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Meb Pharma Consultancy (Opc) Private Limited?

The CIN of Meb Pharma Consultancy (Opc) Private Limited is U24290MH2019OPC330254.

Where is Meb Pharma Consultancy (Opc) Private Limited headquartered?

Meb Pharma Consultancy (Opc) Private Limited is headquartered at Nirmal Nagari Building No F.No.7-A Umred Road Nagpur, Nagpur, Maharashtra, 440009.

When was Meb Pharma Consultancy (Opc) Private Limited incorporated?

Meb Pharma Consultancy (Opc) Private Limited was incorporated on 06 September 2019.

Who are the current directors of Meb Pharma Consultancy (Opc) Private Limited?

The current directors of Meb Pharma Consultancy (Opc) Private Limited are

What is the primary industry of Meb Pharma Consultancy (Opc) Private Limited?

The primary industry of Meb Pharma Consultancy (Opc) Private Limited is Business Outsourcing.

Is Meb Pharma Consultancy (Opc) Private Limited a listed company?

Meb Pharma Consultancy (Opc) Private Limited is unlisted.

What is the capital structure of Meb Pharma Consultancy (Opc) Private Limited?

The authorized capital of Meb Pharma Consultancy (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available